RU2449796C9 - Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива - Google Patents

Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива

Info

Publication number
RU2449796C9
RU2449796C9 RU2002107987/15A RU2002107987A RU2449796C9 RU 2449796 C9 RU2449796 C9 RU 2449796C9 RU 2002107987/15 A RU2002107987/15 A RU 2002107987/15A RU 2002107987 A RU2002107987 A RU 2002107987A RU 2449796 C9 RU2449796 C9 RU 2449796C9
Authority
RU
Russia
Prior art keywords
drospirenone
ethynylestradiol
combination
active agent
daily
Prior art date
Application number
RU2002107987/15A
Other languages
English (en)
Other versions
RU2449796C2 (ru
RU2269342C9 (ru
RU2002107987A (ru
Inventor
Вольфганг ХАЙЛЬ (DE)
Юрген ХИЛЬМАН (DE)
Ральф ЛИПП (DE)
Ренате ХАЙТХЕККЕР (DE)
Original Assignee
Shering Aktsiengezell Shaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2449796(C9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shering Aktsiengezell Shaft filed Critical Shering Aktsiengezell Shaft
Publication of RU2002107987A publication Critical patent/RU2002107987A/ru
Publication of RU2449796C2 publication Critical patent/RU2449796C2/ru
Application granted granted Critical
Publication of RU2269342C9 publication Critical patent/RU2269342C9/ru
Publication of RU2449796C9 publication Critical patent/RU2449796C9/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2002107987/15A 1999-08-31 2000-08-31 Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива RU2449796C9 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
US09/386,274 1999-08-31
EP99202826 1999-08-31
US60/240,953 1999-08-31
EP99202826.6 1999-08-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2005131868/15A Division RU2396082C2 (ru) 1999-08-31 2005-10-14 Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Publications (4)

Publication Number Publication Date
RU2002107987A RU2002107987A (ru) 2004-12-27
RU2449796C2 RU2449796C2 (ru) 2006-02-10
RU2269342C9 RU2269342C9 (ru) 2007-10-27
RU2449796C9 true RU2449796C9 (ru) 2007-10-27

Family

ID=26153358

Family Applications (4)

Application Number Title Priority Date Filing Date
RU2002107987/15A RU2449796C9 (ru) 1999-08-31 2000-08-31 Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
RU2002107987/15K RU2269342C2 (ru) 1999-08-31 2000-08-31 Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
RU2005131868/15A RU2396082C2 (ru) 1999-08-31 2005-10-14 Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
RU2010114825/15A RU2482853C2 (ru) 1999-08-31 2010-04-14 Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Family Applications After (3)

Application Number Title Priority Date Filing Date
RU2002107987/15K RU2269342C2 (ru) 1999-08-31 2000-08-31 Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
RU2005131868/15A RU2396082C2 (ru) 1999-08-31 2005-10-14 Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
RU2010114825/15A RU2482853C2 (ru) 1999-08-31 2010-04-14 Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Country Status (11)

Country Link
CN (1) CN1223350C (ru)
BG (2) BG109749A (ru)
CA (1) CA2382426C (ru)
EE (1) EE05317B1 (ru)
HR (1) HRP20020258B1 (ru)
IL (2) IL197396A (ru)
MX (1) MXPA02002043A (ru)
NO (3) NO327588B3 (ru)
RU (4) RU2449796C9 (ru)
SK (1) SK287634B6 (ru)
UA (1) UA81387C2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält

Also Published As

Publication number Publication date
SK287634B6 (sk) 2011-04-05
RU2482853C2 (ru) 2013-05-27
IL200482A0 (en) 2011-07-31
HRP20020258A2 (en) 2005-02-28
EE05317B1 (et) 2010-08-16
CA2382426A1 (en) 2001-03-08
CN1407895A (zh) 2003-04-02
NO20083854L (no) 2002-04-26
NO20091809L (no) 2002-04-26
HRP20020258B1 (en) 2007-05-31
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
RU2449796C2 (ru) 2006-02-10
CN1223350C (zh) 2005-10-19
RU2269342C9 (ru) 2007-10-27
BG65204B1 (bg) 2007-07-31
MXPA02002043A (es) 2003-08-20
NO327588B3 (no) 2011-05-16
NO327588B1 (no) 2009-08-31
RU2005131868A (ru) 2007-04-20
RU2010114825A (ru) 2011-10-20
BG106533A (bg) 2002-10-31
UA81387C2 (en) 2008-01-10
NO2010004I1 (no) 2010-03-22
SK2572002A3 (en) 2002-11-06
IL197396A (en) 2010-04-29
RU2269342C2 (ru) 2006-02-10
EE200900049A (et) 2009-10-15
RU2396082C2 (ru) 2010-08-10

Similar Documents

Publication Publication Date Title
CA1198057A (en) Method of contraception using peak progestogen dosage
FI98985C (fi) Ehkäisyvalmiste
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
RU2002122113A (ru) Дроспиренон для гормональной заместительной терапии
CA2240329A1 (en) Improved delivery of multiple doses of medications
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
MY144021A (en) Pharmaceutical delivery system
RU2005131868A (ru) Фармацевтическая композиция, фармацевтическая комбинация (варианты) и способы их применения
MY124465A (en) Reduction of infarct volume using citicoline
NZ307178A (en) Medicament for contraception; contains two, separately packed, sequential hormonal components
IL135235A0 (en) Method and composition for preventing nephrotoxicity caused by cyclosporins and tacrolimus
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
EP0235090B1 (en) Composition useful in the treatment of estrogen deficiencies
KR100420673B1 (ko) 지연된구토반응을치료하기위한비강투여제
PL348202A1 (en) Pharmaceutically active composition and dispensing device
RU2002107987A (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
US20080268022A1 (en) Mehtods for treating and preventing ailments caused by human papillomavirus
FI83593B (fi) Antikonceptionssammansaettning.
KR890014109A (ko) 의약제
TW200640468A (en) Pharmaceutical product for oral contraception
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
CA2336711A1 (en) Blister containing a transdermal therapeutic system and a single dose form of administration

Legal Events

Date Code Title Description
TK4A Correction to the publication in the bulletin (patent)

Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 4-2006 FOR TAG: (30)

TH4A Reissue of patent specification
PD4A Correction of name of patent owner
PD4A Correction of name of patent owner
RZ4A Other changes in the information about an invention
TK4A Correction to the publication in the bulletin (patent)

Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 13-2012

RZ4A Other changes in the information about an invention
MF4A Cancelling an invention patent